Lupin

Lupin signs non-exclusive patent license agreement with Takeda to commercialize Vonoprazan in India

Lupin share hits fresh 52-week high after launching Mirabegron Extended-Release Tablets in the United States

Lupin launches Mirabegron Extended-Release Tablets in the United States

Nomura raises target price for Lupin shares, expects stock to rally 10%

Stocks Hitting 52-Week Highs Today: Ajanta Pharma, Lupin, TVS Motor and more

Lupin shares surge 4% after company’s Q1 net profit jumps to ₹801 crore

Lupin shares surge after USFDA clears Gujarat facility

Lupin share price jumps 4% as Kotak ‘double upgrades’ stock to Add from Sell

Lupin shares decline over 2% following Q4 results

Lupin shares surge 3% after launch of generic mirabegron tablets in US

Lupin shares surge after drug maker launches first generic version of doxycycline capsule

Lupin shares decline nearly 2% amidst USFDA observation

Stocks To Watch Today: Tata Consumer Products, Lupin, Mankind Pharma, SJVN

Top stocks to watch today are Tata Consumer Products, Lupin, Mankind Pharma, SJVN.

Stocks To Watch Today: Britannia, Nykaa, NLC India, Lupin, Biocon, Kotak Mahindra Bank

Top stocks to watch today are Britannia, Nykaa, NLC India, Lupin, Biocon, and Kotak Mahindra Bank.

Lupin gains as USFDA approves stroke risk reduction tablets